Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gianmarco Bagnato"'
Autor:
Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
We report the case of 2 patients with relapsed/refractory peripheral T-cell lymphoma treated with valemetostat tosilate, a selective dual inhibitor of histone-lysine N-methyltransferases enhancer of zeste homolog 1 and 2, and subsequently bridged to
Externí odkaz:
https://doaj.org/article/f3bcfe6454db4c48926e6d674464f884
Autor:
Alessandro Broccoli, Lisa Argnani, Laura Nanni, Gianmarco Bagnato, Matteo Carella, Beatrice Casadei, Paolo Elia Coppola, Gabriele Gugliotta, Ginevra Lolli, Marianna Gentilini, Alice Morigi, Cinzia Pellegrini, Vittorio Stefoni, Pier Luigi Zinzani
Publikováno v:
Blood. 140:6526-6527
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47eec964d801c6c7c8851fe75a037e0e
https://doi.org/10.1182/blood-2022-158158
https://doi.org/10.1182/blood-2022-158158
Autor:
Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, Shai Shimony, Oren Pasvolsky, Tamar Berger, Gilad Itchaki, Pia Raanani, Alessandro Broccoli, Vittorio Stefoni Stefoni, Ginevra Lolli, Lisa Argnani, Pier Luigi Zinzani, Ronit Gurion
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S370-S371
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68ebdd54a56bcb6b771da8ba31b6bb8c
https://doi.org/10.1016/s2152-2650(22)01524-5
https://doi.org/10.1016/s2152-2650(22)01524-5
Autor:
Alessandro Broccoli, Lisa Argnani, Paolo Elia Coppola, Marianna Gentilini, Gianmarco Bagnato, Ginevra Lolli, Matteo Carella, Laura Nanni, Alice Morigi, Beatrice Casadei, Cinzia Pellegrini, Vittorio Stefoni, Pier Luigi Zinzani
The follow-up of the pivotal trial and large case series reports of a proportion of patients, between 5% and 9%, with relapsed or refractory Hodgkin lymphoma failing autologous stem cell transplantation and treated with brentuximab vedotin, achieving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90577faf1568d29decfb39b1bdfdc6de
http://hdl.handle.net/11585/882767
http://hdl.handle.net/11585/882767
Autor:
Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, Shai Shimony, Oren Pasvolsky, Tamar Berger, Gilad Itchaki, Pia Raanani, Alessandro Broccoli, Vittorio Stefoni Stefoni, Ginevra Lolli, Lisa Argnani, Pier Luigi Zinzani, Ronit Gurion
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S169
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4094526c5c18ef680bae094d50f54d4
https://doi.org/10.1016/s2152-2650(22)01037-0
https://doi.org/10.1016/s2152-2650(22)01037-0
Autor:
Adrián Mosquera Orgueira, Gerardo Musuraca, Giovanni Martinelli, Giorgia Simonetti, Claudio Cerchione, Maria Benedetta Giannini, Gianmarco Bagnato, Giovanni Marconi
Publikováno v:
Expert opinion on drug safety. 20(7)
FLT3 inhibitors are important drugs in the therapy of FLT3 positive acute myeloid leukemia (AML). Midostaurin was registered in combination with chemotherapy to treat newly diagnosed AML. Gilteritinib and quizartinib demonstrate effectiveness in a ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6742032995e8f6f4715161b6d4dcc1f
https://pubmed.ncbi.nlm.nih.gov/33853481
https://pubmed.ncbi.nlm.nih.gov/33853481